Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asim Amin

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|November 10, 2016
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in PakistanMuhammad U Rashid, Noor Muhammad, Asim Amin, et al.
BMC Cancer|June 29, 2013
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from PakistanMuhammad U Rashid, Noor Muhammad, Saima Faisal, et al.
Familial Cancer|February 8, 2012
Prevalence of TP53 germ line mutations in young Pakistani breast cancer patientsMuhammad U Rashid, Sidra Gull, Kashif Asghar, et al.
Urologic Oncology|October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Melanoma Research|November 5, 2011
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trialJeffrey S Weber, Asim Amin, David Minor, et al.
Thrombosis Research|November 6, 2021
Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapyHailey Hill, Myra Robinson, Lauren Lu, et al.
Pathology, Research and Practice|July 5, 2011
A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinomaMuhammad U Rashid, Mazher A Shah, Rafay Azhar, et al.
Melanoma Research|July 22, 2024
Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysisJoseph B Elmes, Jessica M Davis, Laura W Musselwhite, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse modelDavid M Foureau, Iain H McKillop, Chase P Jones, et al.
Familial Cancer|July 14, 2011
Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from PakistanMuhammad U Rashid, Sidra Gull, Saima Faisal, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|November 10, 2016
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in PakistanMuhammad U Rashid, Noor Muhammad, Asim Amin, et al.
BMC Cancer|June 29, 2013
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from PakistanMuhammad U Rashid, Noor Muhammad, Saima Faisal, et al.
Familial Cancer|February 8, 2012
Prevalence of TP53 germ line mutations in young Pakistani breast cancer patientsMuhammad U Rashid, Sidra Gull, Kashif Asghar, et al.
Urologic Oncology|October 7, 2004
9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901Asim Amin, Susan Halabi, Edward P Gelmann, et al.
Melanoma Research|November 5, 2011
Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trialJeffrey S Weber, Asim Amin, David Minor, et al.
Thrombosis Research|November 6, 2021
Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapyHailey Hill, Myra Robinson, Lauren Lu, et al.
Pathology, Research and Practice|July 5, 2011
A deleterious BRCA1 mutation in a young Pakistani woman with metaplastic breast carcinomaMuhammad U Rashid, Mazher A Shah, Rafay Azhar, et al.
Melanoma Research|July 22, 2024
Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysisJoseph B Elmes, Jessica M Davis, Laura W Musselwhite, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2011
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse modelDavid M Foureau, Iain H McKillop, Chase P Jones, et al.
Familial Cancer|July 14, 2011
Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from PakistanMuhammad U Rashid, Sidra Gull, Saima Faisal, et al.
Pageof 6